title: Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.
abstract: Resistant hypertension remains a challenging issue even for modern medicine. Therefore, research is focusing on the development of new technologies to optimize the treatment of this condition. It has been demonstrated that the dysfunction of the sympathetic nervous system is crucial in the development and maintenance of advanced stages of hypertension. Based on these findings, clinical trials have recently shown that catheter-based percutaneous renal denervation therapy is safe and effective in the treatment of resistant hypertension. This review discusses the current scientific knowledge of renal denervation therapy in resistant hypertension, including the different methods that have been described in the literature so far, as well as limitations of the available data. Furthermore, new potential targets for this fascinating therapy will be addressed.
authors.affiliation: Department of Internal Medicine I, Friedrich Schiller University, Jena, Germany. dirk.prochnau@med.uni-jena.de
authors.forename: Dirk
authors.initials: D
authors.lastname: Prochnau
authors.forename: Hans R
authors.initials: HR
authors.lastname: Figulla
authors.forename: Ralf
authors.initials: R
authors.lastname: Surber
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D062186:Arterial Pressure / Q000187:drug effects*; D017115:Catheter Ablation / Q000266:history; D004351:Drug Resistance; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000266:history / Q000503:physiopathology / Q000601:surgery*; D007668:Kidney / Q000294:innervation*; D013562:Sympathectomy / Q000266:history / Q000379:methods*
chemical_list: D000959:Antihypertensive Agents